Condition
Essential Thrombocythemia (ET) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Essential Thrombocythemia (ET) clinical trials that are recruiting, at sites in 4 countries (most in United States (2), China (1), Australia (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Essential Thrombocythemia (ET) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Orally administered JBI-802 in certain blood cancers with high platelets | Phase 1/2 | Sydney, New South Wales and 6 other locations | Recruiting | May 28, 2026 |
| Identifying MPN-Specific Immune Targets in Blood and Bone Marrow | — | Brussels, Woluwe | Recruiting | May 15, 2026 |
| MPN PROGRESSion Registry — tracking symptoms, treatments, and disease progression in people with MPNs. | — | Chicago, Illinois and 1 other locations | Recruiting | Jan 23, 2026 |
| Using low-dose Methotrexate for treating blood cancers | Phase 2 | New York, New York | Recruiting | Aug 7, 2024 |
| Long-term study of blood diseases in patients in China | — | Tianjin, Tianjin Municipality | Recruiting | Nov 27, 2020 |
All recruiting trials (5)
-
Orally administered JBI-802 in certain blood cancers with high platelets
This study tests whether taking JBI-802 by mouth can be safe and helpful for adults with essential thrombocythemia or related blood cancers that involve high platelet counts.
-
Identifying MPN-Specific Immune Targets in Blood and Bone Marrow
This study tests whether certain T cells in adults with MPN can recognize MPN cells and what antigens those T cells target.
-
MPN PROGRESSion Registry — tracking symptoms, treatments, and disease progression in people with MPNs.
Track long-term symptoms, treatments, and disease progression in adults with myeloproliferative neoplasms to see how these conditions evolve over time.
-
Using low-dose Methotrexate for treating blood cancers
This study is testing if adding low-dose Methotrexate to the treatment of blood cancers like Polycythemia Vera and Myelofibrosis can help reduce symptoms and improve spleen size for patients.
-
Long-term study of blood diseases in patients in China
This study is trying to gather detailed information from patients in China with blood diseases like leukemia and multiple myeloma to better understand how these conditions affect their lives and treatment options.
Related topics
Quick answers
How many Essential Thrombocythemia (ET) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (1 trial), Australia (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.